|
所属 |
附属病院 病理部 |
研究等業績 【 表示 ／ 非表示 】
-
4times in situ transient one-hour flow decrease can induce intimal thickening and medial remodeling of flow-remodeled artery
Nanjo， H.， Komatsu， M.， Masuda， H， et al
Microcirculation annual 19 45 - 46 2003年01月
研究論文（学術雑誌） 国内共著
-
秋田エキノコックス侵入報道（誤報）の顛末
南條 博
医学のあゆみ 201 ( 8 ) 550 - 551 2003年01月
研究論文（学術雑誌） 単著
-
Ultrastructure of endothelial cells under flow alteration
Masuda， H.， Kawamura， K.， Nanjo， H.， et al
Microsc Res Tech 60 2 - 12 2003年01月
研究論文（学術雑誌） 国内共著
-
High flow derives vascular endothelial cell proliferation during flow-inducued arterial remodeling associated with the expression of vascular endothelial growth factors
Sho， E.， Komatsu， M.， Nanjo， H.， et al
Experimental and Molecular Pathology 75 1 - 11 2003年01月 [査読有り]
研究論文（学術雑誌） 国内共著
-
Efficacy of continuous infusion of prostaglandin E1 through the superior mesenteric artery against ischemic liver cell necrosis after hepatic artery occlusion
Kato， T.， Sato， T.， Kurokawa， T.， Nanjo， H.， et al:
Transplantation 76 1340 - 1345 2003年01月 [査読有り]
研究論文（学術雑誌） 国内共著
-
Sugawara D.
Abdominal Radiology ( Abdominal Radiology ) 2026年
-
Kimura Kazuya, Watanabe Kenta, Kobayashi Mizuki, Okubo Keisuke, Sato Hiromi, Narita Shintaro, Wada Yuki, Kumagai Satoshi, Sato Kimihiko, Fukuda Sho, Yoshida Tatsuki, Kodama So, Saruta Yohei, Abe Ryo, Shimodaira Yosuke, Matsuhashi Tamotsu, Arita Junichi, Mori Naoko, Nanjo Hiroshi, Habuchi Tomonori, Iijima Katsunori
Internal Medicine ( 一般社団法人 日本内科学会 ) advpub ( 0 ) 2026年
<p>Hydrogel spacers are commonly used to reduce rectal toxicity during radiation therapy for prostate cancer. Although generally safe, rare, serious complications may occur. We report the case of a man with diabetes and renal failure who developed a refractory rectal ulcer and fistula five months after spacer placement, followed by Fournier's gangrene. The patient recovered following surgical drainage and antibiotic therapy. This is the first reported case of Fournier's gangrene following hydrogel spacer insertion. Spacer-related rectal wall infiltration might have contributed to this finding. Clinicians should recognize such adverse events and consider early intervention in high-risk patients presenting with hematochezia or perineal symptoms. </p>
-
Prognostic Impact of Clinical Diagnosis-based Treatment in Glioblastoma Patients Aged ≥80 Years: A Single-center Cohort Study Focused on Performance Status Maintenance
ONO Takahiro, SAITO Ayana, ABE Masamichi, NANJO Hiroshi, SHIMIZU Hiroaki
Neurologia medico-chirurgica ( 一般社団法人 日本脳神経外科学会 ) advpub ( 0 ) 2026年
<p>In aging societies such as Japan, the number of patients aged ≥80 years with glioblastoma who are unsuited for surgery is rapidly increasing. At our institution, we adopted a therapeutic strategy based on clinical diagnosis without histological confirmation when surgery was not feasible. This study aimed to retrospectively evaluate the short-term outcomes and clinical value of surgical intervention and histological confirmation in this population. Patients aged ≥80 years diagnosed with glioblastoma between 2011 and 2025 were reviewed. Clinical diagnosis was applied when patients were unfit for surgery. Patient data, including age, sex, Karnofsky performance status, extent of resection, treatment options, and complications, were analyzed for associations with overall survival, Karnofsky performance status improvement, and discharge home. Among 203 cases, 31 patients (15.3%) were included. Their mean age was 84 years; the median Karnofsky performance status scores at admission and discharge were 50 and 60, respectively. Six patients underwent resection, 14 biopsy, and 11 clinical diagnosis. The clinical diagnosis group showed better functional outcomes, including improved Karnofsky performance status, shorter hospitalization, and higher discharge home rates than the biopsy group. Bevacizumab contributed significantly to these outcomes. Perioperative complications occurred in 4 patients; none recovered functionally or were discharged home. Low Karnofsky performance status at discharge was the only independent predictor of poor overall survival. Surgical intervention did not significantly affect the functional and survival outcomes. In conclusion, clinical diagnosis-based treatment, particularly with bevacizumab, could help preserve function and facilitate discharge in very elderly patients with glioblastoma. Biopsies might negatively impact the outcomes in the present cohort.</p>
-
Fukuda S.
Clinical Journal of Gastroenterology ( Clinical Journal of Gastroenterology ) 18 ( 6 ) 1108 - 1113 2025年12月
-
Sejimo Y.
Gynecologic Oncology Reports ( Gynecologic Oncology Reports ) 62 2025年12月